Original Research

Deployment-Related Lung Disorders

Deployment in southwest Asia is associated with a wide range of respiratory disorders related to tobacco use and to workplace and environmental exposures.

Author and Disclosure Information

 

References

Military deployed from World War II through the Vietnam War have had enough time for respiratory disorders with both short and long latencies to manifest. More recent deployments over the past 13 years to Iraq, Kuwait, Afghanistan, and other regions in southwest Asia (SWA) have been associated with a unique spectrum of respiratory disorders. The long-term respiratory effects of SWA deployments are unknown. This review will discuss deployment-related lung cancer and then focus primarily on the emerging respiratory disorders related to SWA deployment and case examples of deployment-related lung disease.

As the number of recent veterans in the VA health care system increases, primary care providers (PCPs) and specialists are increasingly faced with questions about potential hazards of deployment, referring patients to the VA Airborne Hazards and Open Burn Pit Registry, and evaluating patients with new-onset respiratory symptoms following deployment. Previous reviews and white papers have offered recommendations for evaluation and management; however, little has been reported in the form of case examples of patients with deployment-related lung disorders and their clinical course. 1,2

Deployment-Associated Lung Cancer

Lung cancer is the leading cause of cancer death in the U.S. and around the world. 3 Lung cancer in the U.S. causes more deaths than does the combination of breast, prostate, colon, and rectal cancers. Lung cancer is the second most common cancer and causes more deaths than does any other cancer in the VHA. 4 Most cancers with an environmental cause have a significant latent period of decades between the exposure and cancer incidence. Thus, although lung cancer risk is relatively low in active-duty military personnel, the rate of lung cancer in VA patients is nearly double that of the general population, suggesting causes associated with military service. 5

Tobacco

The main cause of lung cancer is tobacco smoking, which accounts for 85% to 90% of lung cancer in the U.S. The latent period between initiation of tobacco smoking and lung cancer incidence is typically ≥ 30 years. Military service has long been associated with tobacco smoking, due to past practices that included the provision of free cigarettes, the availability of cigarettes at reduced cost, smoking breaks, perceived relief from both stress and boredom, and social factors. 6 More recently, the adverse effects (AEs) of smoking on health and readiness have been appreciated, and many incentives encouraging tobacco smoking have been eliminated. In 2009, the Institute of Medicine called for a tobacco-free military, and both the Secretary of the Navy and Secretary of Defense have seriously considered this change. 7

The additional effect of deployment on smoking has been reported. 8 The longitudinal Millennium Cohort study compared several smoking measures between 55,021 deployers and nondeployers who completed both baseline (acquired July 2001-June 2003) and follow-up questionnaires (acquired June 2004-January 2006). Smoking initiation affected 2.3% of deployers and 1.3% of nondeployers; smoking resumption showed a similar pattern with an increase of 39.4% compared with 28.7%. The overall prevalence of smoking increased 44% among nondeployers and 57% among deployers. Those never smokers exposed to combat were 60% more likely to initiate smoking compared with noncombat deployers. Thus, it is clear that tobacco smoking should be considered a deployment-related exposure that contributes to lung cancer risk.

Pages

Recommended Reading

NSAIDs Linked to Poor Pneumonia Outcomes
Federal Practitioner
Pulmonary Vein Thrombosis Associated With Metastatic Carcinoma
Federal Practitioner
HIV-Negative Patients at Risk for Pneumocystosis
Federal Practitioner
Comparing Surveillance Methods for Ventilator-Associated Pneumonia
Federal Practitioner
Identification and Management of Middle East Respiratory Syndrome
Federal Practitioner
Risk of Readmission After Pneumonia
Federal Practitioner
Venous Thromboembolism Prophylaxis in Acutely Ill Veterans With Respiratory Disease
Federal Practitioner
Ceftaroline for MRSA-Related Pneumonia
Federal Practitioner
ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
Federal Practitioner
Spirometry Underused for Asthma Patients
Federal Practitioner

Related Articles